Structure

Physi-Chem Properties

Molecular Weight:  372.12
Volume:  369.247
LogP:  3.075
LogD:  2.879
LogS:  -4.765
# Rotatable Bonds:  6
TPSA:  76.36
# H-Bond Aceptor:  7
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.655
Synthetic Accessibility Score:  2.269
Fsp3:  0.25
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.575
MDCK Permeability:  5.499178223544732e-05
Pgp-inhibitor:  0.997
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.059

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.132
Plasma Protein Binding (PPB):  69.82254028320312%
Volume Distribution (VD):  0.847
Pgp-substrate:  25.572818756103516%

ADMET: Metabolism

CYP1A2-inhibitor:  0.364
CYP1A2-substrate:  0.983
CYP2C19-inhibitor:  0.49
CYP2C19-substrate:  0.894
CYP2C9-inhibitor:  0.504
CYP2C9-substrate:  0.901
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.933
CYP3A4-inhibitor:  0.718
CYP3A4-substrate:  0.708

ADMET: Excretion

Clearance (CL):  6.633
Half-life (T1/2):  0.457

ADMET: Toxicity

hERG Blockers:  0.066
Human Hepatotoxicity (H-HT):  0.138
Drug-inuced Liver Injury (DILI):  0.931
AMES Toxicity:  0.267
Rat Oral Acute Toxicity:  0.14
Maximum Recommended Daily Dose:  0.07
Skin Sensitization:  0.312
Carcinogencity:  0.057
Eye Corrosion:  0.003
Eye Irritation:  0.022
Respiratory Toxicity:  0.259

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC136278

Natural Product ID:  NPC136278
Common Name*:   7,8,3',4',5'-Pentamethoxyflavone
IUPAC Name:   7,8-dimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one
Synonyms:   7,8,3',4',5'-Pentamethoxyflavone
Standard InCHIKey:  IQXUAKMLDBLFJK-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C20H20O7/c1-22-14-7-6-12-13(21)10-15(27-18(12)20(14)26-5)11-8-16(23-2)19(25-4)17(9-11)24-3/h6-10H,1-5H3
SMILES:  COc1cc(cc(c1OC)OC)c1cc(=O)c2c(o1)c(OC)c(cc2)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465255
PubChem CID:   24750458
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0002585] O-methylated flavonoids
          • [CHEMONTID:0002593] 8-O-methylated flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8046 Muntingia calabura Species Muntingiaceae Eukaryota n.a. root n.a. PMID[2045815]
NPO8046 Muntingia calabura Species Muntingiaceae Eukaryota Roots n.a. n.a. PMID[2045815]
NPO8046 Muntingia calabura Species Muntingiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8046 Muntingia calabura Species Muntingiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8046 Muntingia calabura Species Muntingiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 > 25.0 ug ml-1 PMID[455163]
NPT83 Cell Line MCF7 Homo sapiens ED50 > 25.0 ug ml-1 PMID[455163]
NPT139 Cell Line HT-29 Homo sapiens ED50 > 25.0 ug ml-1 PMID[455163]
NPT916 Cell Line SK-MEL Homo sapiens ED50 > 25.0 ug ml-1 PMID[455163]
NPT375 Cell Line Malme-3M Homo sapiens ED50 > 25.0 ug ml-1 PMID[455163]
NPT13 Individual Protein Tyrosine-protein kinase LCK Homo sapiens IC50 > 800.0 ug.mL-1 PMID[455164]
NPT2 Others Unspecified IC50 > 800.0 ug.mL-1 PMID[455161]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC136278 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9928 High Similarity NPC113089
0.9857 High Similarity NPC205522
0.9855 High Similarity NPC70853
0.9855 High Similarity NPC9966
0.9786 High Similarity NPC106461
0.9786 High Similarity NPC40818
0.9786 High Similarity NPC110639
0.9786 High Similarity NPC14958
0.9786 High Similarity NPC215932
0.9783 High Similarity NPC29536
0.9716 High Similarity NPC85233
0.9716 High Similarity NPC299923
0.9714 High Similarity NPC471590
0.9648 High Similarity NPC63256
0.9648 High Similarity NPC10304
0.9645 High Similarity NPC283002
0.9645 High Similarity NPC310259
0.9645 High Similarity NPC302408
0.9643 High Similarity NPC23955
0.9643 High Similarity NPC293201
0.958 High Similarity NPC69752
0.9574 High Similarity NPC165512
0.9517 High Similarity NPC39732
0.9517 High Similarity NPC60972
0.9514 High Similarity NPC201547
0.9514 High Similarity NPC259058
0.951 High Similarity NPC195202
0.951 High Similarity NPC261548
0.9507 High Similarity NPC195919
0.9507 High Similarity NPC216314
0.9507 High Similarity NPC231013
0.9507 High Similarity NPC120924
0.95 High Similarity NPC214919
0.95 High Similarity NPC124467
0.95 High Similarity NPC185607
0.9493 High Similarity NPC44573
0.9452 High Similarity NPC186507
0.9452 High Similarity NPC472408
0.9448 High Similarity NPC308451
0.9448 High Similarity NPC226973
0.9448 High Similarity NPC208043
0.9444 High Similarity NPC238366
0.9444 High Similarity NPC181250
0.9441 High Similarity NPC33265
0.9441 High Similarity NPC117463
0.9441 High Similarity NPC62536
0.9441 High Similarity NPC470511
0.9441 High Similarity NPC12200
0.9429 High Similarity NPC58229
0.9388 High Similarity NPC256612
0.9388 High Similarity NPC20830
0.9384 High Similarity NPC40033
0.9384 High Similarity NPC166201
0.9384 High Similarity NPC134677
0.9379 High Similarity NPC189270
0.9379 High Similarity NPC50728
0.9379 High Similarity NPC5840
0.9379 High Similarity NPC166753
0.9379 High Similarity NPC306821
0.9375 High Similarity NPC476342
0.9366 High Similarity NPC182842
0.9348 High Similarity NPC77955
0.9324 High Similarity NPC265511
0.932 High Similarity NPC145379
0.932 High Similarity NPC128961
0.932 High Similarity NPC274327
0.932 High Similarity NPC69394
0.932 High Similarity NPC176775
0.932 High Similarity NPC280937
0.932 High Similarity NPC183878
0.932 High Similarity NPC86485
0.932 High Similarity NPC47781
0.932 High Similarity NPC231018
0.932 High Similarity NPC22519
0.932 High Similarity NPC472915
0.932 High Similarity NPC160951
0.932 High Similarity NPC255350
0.9315 High Similarity NPC472535
0.9315 High Similarity NPC474388
0.9315 High Similarity NPC236769
0.9315 High Similarity NPC474170
0.931 High Similarity NPC52005
0.931 High Similarity NPC137062
0.931 High Similarity NPC48479
0.931 High Similarity NPC177298
0.931 High Similarity NPC474648
0.931 High Similarity NPC328119
0.931 High Similarity NPC223579
0.931 High Similarity NPC159103
0.931 High Similarity NPC287101
0.931 High Similarity NPC183950
0.9296 High Similarity NPC476054
0.9262 High Similarity NPC19097
0.9262 High Similarity NPC476981
0.9257 High Similarity NPC241774
0.9257 High Similarity NPC146165
0.9257 High Similarity NPC34725
0.9257 High Similarity NPC50715
0.9257 High Similarity NPC128863
0.9257 High Similarity NPC163780
0.9257 High Similarity NPC189960
0.9257 High Similarity NPC122623
0.9257 High Similarity NPC183597
0.9257 High Similarity NPC284353
0.9257 High Similarity NPC167815
0.9257 High Similarity NPC208197
0.9257 High Similarity NPC227325
0.9257 High Similarity NPC255807
0.9257 High Similarity NPC2476
0.9257 High Similarity NPC196439
0.9257 High Similarity NPC276059
0.9257 High Similarity NPC138360
0.9257 High Similarity NPC280339
0.9257 High Similarity NPC4455
0.9257 High Similarity NPC213622
0.9257 High Similarity NPC201136
0.9257 High Similarity NPC32557
0.9257 High Similarity NPC31018
0.9257 High Similarity NPC92659
0.9252 High Similarity NPC212678
0.9252 High Similarity NPC71334
0.9252 High Similarity NPC100887
0.9252 High Similarity NPC301123
0.9252 High Similarity NPC275836
0.9252 High Similarity NPC301323
0.9252 High Similarity NPC275722
0.9252 High Similarity NPC239128
0.9252 High Similarity NPC25270
0.9252 High Similarity NPC83508
0.9252 High Similarity NPC156222
0.9252 High Similarity NPC57030
0.9252 High Similarity NPC477231
0.9252 High Similarity NPC55205
0.9252 High Similarity NPC293183
0.9252 High Similarity NPC256283
0.9252 High Similarity NPC292460
0.9252 High Similarity NPC187498
0.9252 High Similarity NPC162313
0.9252 High Similarity NPC198826
0.9252 High Similarity NPC68882
0.9252 High Similarity NPC257648
0.9252 High Similarity NPC188203
0.9252 High Similarity NPC131624
0.9252 High Similarity NPC241498
0.9252 High Similarity NPC120163
0.9252 High Similarity NPC222830
0.9247 High Similarity NPC177839
0.9247 High Similarity NPC219330
0.9241 High Similarity NPC183236
0.9241 High Similarity NPC120464
0.9195 High Similarity NPC49824
0.9195 High Similarity NPC257277
0.9195 High Similarity NPC180340
0.9195 High Similarity NPC178854
0.9195 High Similarity NPC472455
0.9195 High Similarity NPC472916
0.9189 High Similarity NPC270620
0.9189 High Similarity NPC250822
0.9189 High Similarity NPC75279
0.9189 High Similarity NPC236223
0.9189 High Similarity NPC476289
0.9189 High Similarity NPC279930
0.9189 High Similarity NPC179126
0.9189 High Similarity NPC78326
0.9189 High Similarity NPC276409
0.9184 High Similarity NPC54394
0.9184 High Similarity NPC117579
0.9184 High Similarity NPC262623
0.9184 High Similarity NPC149614
0.9184 High Similarity NPC474663
0.9184 High Similarity NPC31363
0.9184 High Similarity NPC125062
0.9184 High Similarity NPC76376
0.9184 High Similarity NPC198615
0.9184 High Similarity NPC200740
0.9184 High Similarity NPC252933
0.9172 High Similarity NPC119660
0.9172 High Similarity NPC93034
0.9172 High Similarity NPC474999
0.9172 High Similarity NPC168803
0.9172 High Similarity NPC108406
0.9161 High Similarity NPC119663
0.9143 High Similarity NPC254741
0.9139 High Similarity NPC476980
0.9133 High Similarity NPC224137
0.9133 High Similarity NPC129684
0.9133 High Similarity NPC227192
0.9133 High Similarity NPC203891
0.9133 High Similarity NPC101830
0.9133 High Similarity NPC75215
0.9133 High Similarity NPC93376
0.9133 High Similarity NPC310206
0.9133 High Similarity NPC189179
0.9133 High Similarity NPC110070
0.9133 High Similarity NPC299520
0.9133 High Similarity NPC181960
0.9133 High Similarity NPC470402
0.913 High Similarity NPC473655
0.913 High Similarity NPC101294
0.9128 High Similarity NPC26227

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC136278 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.932 High Similarity NPD2801 Approved
0.9128 High Similarity NPD3817 Phase 2
0.9013 High Similarity NPD5494 Approved
0.9007 High Similarity NPD2796 Approved
0.8993 High Similarity NPD1934 Approved
0.8966 High Similarity NPD1511 Approved
0.894 High Similarity NPD3882 Suspended
0.8844 High Similarity NPD1512 Approved
0.8808 High Similarity NPD2393 Clinical (unspecified phase)
0.8671 High Similarity NPD3818 Discontinued
0.8649 High Similarity NPD4378 Clinical (unspecified phase)
0.8599 High Similarity NPD3926 Phase 2
0.859 High Similarity NPD1247 Approved
0.8581 High Similarity NPD6799 Approved
0.8544 High Similarity NPD6166 Phase 2
0.8544 High Similarity NPD6168 Clinical (unspecified phase)
0.8544 High Similarity NPD6167 Clinical (unspecified phase)
0.85 High Similarity NPD7054 Approved
0.8462 Intermediate Similarity NPD919 Approved
0.8447 Intermediate Similarity NPD7472 Approved
0.8414 Intermediate Similarity NPD1510 Phase 2
0.8411 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8367 Intermediate Similarity NPD1549 Phase 2
0.8366 Intermediate Similarity NPD4380 Phase 2
0.8333 Intermediate Similarity NPD7074 Phase 3
0.8333 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD7819 Suspended
0.8323 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD6232 Discontinued
0.8299 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8299 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD7808 Phase 3
0.8293 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8282 Intermediate Similarity NPD6797 Phase 2
0.828 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8278 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8269 Intermediate Similarity NPD5402 Approved
0.8264 Intermediate Similarity NPD1240 Approved
0.8261 Intermediate Similarity NPD7473 Discontinued
0.8258 Intermediate Similarity NPD6801 Discontinued
0.8247 Intermediate Similarity NPD6599 Discontinued
0.8232 Intermediate Similarity NPD7251 Discontinued
0.8207 Intermediate Similarity NPD1933 Approved
0.817 Intermediate Similarity NPD920 Approved
0.8165 Intermediate Similarity NPD7075 Discontinued
0.8163 Intermediate Similarity NPD3748 Approved
0.8151 Intermediate Similarity NPD1607 Approved
0.8082 Intermediate Similarity NPD447 Suspended
0.8077 Intermediate Similarity NPD7411 Suspended
0.8067 Intermediate Similarity NPD1243 Approved
0.8052 Intermediate Similarity NPD5403 Approved
0.8049 Intermediate Similarity NPD5844 Phase 1
0.8039 Intermediate Similarity NPD5401 Approved
0.8039 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD943 Approved
0.8 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD1465 Phase 2
0.7925 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD3750 Approved
0.7877 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD6832 Phase 2
0.7844 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD5242 Approved
0.7791 Intermediate Similarity NPD6959 Discontinued
0.777 Intermediate Similarity NPD5536 Phase 2
0.7755 Intermediate Similarity NPD2313 Discontinued
0.7748 Intermediate Similarity NPD2935 Discontinued
0.7748 Intermediate Similarity NPD1551 Phase 2
0.7746 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD6386 Approved
0.7736 Intermediate Similarity NPD6385 Approved
0.7718 Intermediate Similarity NPD230 Phase 1
0.7716 Intermediate Similarity NPD3749 Approved
0.7712 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD2800 Approved
0.7702 Intermediate Similarity NPD5353 Approved
0.7692 Intermediate Similarity NPD6559 Discontinued
0.7682 Intermediate Similarity NPD2799 Discontinued
0.7662 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD7768 Phase 2
0.7651 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD3226 Approved
0.7603 Intermediate Similarity NPD2798 Approved
0.7597 Intermediate Similarity NPD2654 Approved
0.7582 Intermediate Similarity NPD2346 Discontinued
0.7582 Intermediate Similarity NPD2344 Approved
0.758 Intermediate Similarity NPD2532 Approved
0.758 Intermediate Similarity NPD2533 Approved
0.758 Intermediate Similarity NPD2534 Approved
0.7576 Intermediate Similarity NPD7199 Phase 2
0.7566 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD3018 Phase 2
0.7548 Intermediate Similarity NPD4628 Phase 3
0.7545 Intermediate Similarity NPD2403 Approved
0.7533 Intermediate Similarity NPD1613 Approved
0.7533 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD3751 Discontinued
0.7451 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD3027 Phase 3
0.7448 Intermediate Similarity NPD3972 Approved
0.7448 Intermediate Similarity NPD2981 Phase 2
0.744 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD9494 Approved
0.7427 Intermediate Similarity NPD5953 Discontinued
0.7425 Intermediate Similarity NPD3787 Discontinued
0.7417 Intermediate Similarity NPD4307 Phase 2
0.7415 Intermediate Similarity NPD3266 Approved
0.7415 Intermediate Similarity NPD3267 Approved
0.7415 Intermediate Similarity NPD1203 Approved
0.7412 Intermediate Similarity NPD7286 Phase 2
0.7403 Intermediate Similarity NPD6099 Approved
0.7403 Intermediate Similarity NPD6100 Approved
0.7397 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7397 Intermediate Similarity NPD2982 Phase 2
0.7397 Intermediate Similarity NPD2983 Phase 2
0.7389 Intermediate Similarity NPD2309 Approved
0.7365 Intermediate Similarity NPD1019 Discontinued
0.7362 Intermediate Similarity NPD6844 Discontinued
0.7362 Intermediate Similarity NPD37 Approved
0.7361 Intermediate Similarity NPD17 Approved
0.7357 Intermediate Similarity NPD1241 Discontinued
0.7355 Intermediate Similarity NPD1471 Phase 3
0.7341 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD5019 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4965 Approved
0.7333 Intermediate Similarity NPD4967 Phase 2
0.7333 Intermediate Similarity NPD4966 Approved
0.7329 Intermediate Similarity NPD9717 Approved
0.7329 Intermediate Similarity NPD1653 Approved
0.732 Intermediate Similarity NPD6651 Approved
0.7296 Intermediate Similarity NPD4357 Discontinued
0.7288 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD3268 Approved
0.7285 Intermediate Similarity NPD1296 Phase 2
0.7278 Intermediate Similarity NPD6190 Approved
0.7246 Intermediate Similarity NPD6234 Discontinued
0.7234 Intermediate Similarity NPD5283 Phase 1
0.7226 Intermediate Similarity NPD7033 Discontinued
0.7226 Intermediate Similarity NPD4308 Phase 3
0.7222 Intermediate Similarity NPD1548 Phase 1
0.7215 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD1608 Approved
0.7205 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD7390 Discontinued
0.7184 Intermediate Similarity NPD7685 Pre-registration
0.7181 Intermediate Similarity NPD2797 Approved
0.7172 Intermediate Similarity NPD9268 Approved
0.7171 Intermediate Similarity NPD411 Approved
0.717 Intermediate Similarity NPD3887 Approved
0.7169 Intermediate Similarity NPD5978 Approved
0.7169 Intermediate Similarity NPD5977 Approved
0.7169 Intermediate Similarity NPD4288 Approved
0.7152 Intermediate Similarity NPD6280 Approved
0.7152 Intermediate Similarity NPD4908 Phase 1
0.7152 Intermediate Similarity NPD6279 Approved
0.7143 Intermediate Similarity NPD3146 Approved
0.7143 Intermediate Similarity NPD422 Phase 1
0.7143 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD2353 Approved
0.7119 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD7229 Phase 3
0.7114 Intermediate Similarity NPD3225 Approved
0.7114 Intermediate Similarity NPD1876 Approved
0.7111 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD9269 Phase 2
0.7091 Intermediate Similarity NPD5890 Approved
0.7091 Intermediate Similarity NPD5889 Approved
0.7083 Intermediate Similarity NPD6971 Discontinued
0.7079 Intermediate Similarity NPD8434 Phase 2
0.7078 Intermediate Similarity NPD3142 Approved
0.7078 Intermediate Similarity NPD3140 Approved
0.707 Intermediate Similarity NPD3539 Phase 1
0.7059 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6798 Discontinued
0.7052 Intermediate Similarity NPD2163 Approved
0.7052 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD1652 Phase 2
0.7043 Intermediate Similarity NPD5006 Approved
0.7043 Intermediate Similarity NPD5005 Approved
0.7039 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD4662 Approved
0.7037 Intermediate Similarity NPD4661 Approved
0.7033 Intermediate Similarity NPD4363 Phase 3
0.7033 Intermediate Similarity NPD4360 Phase 2
0.703 Intermediate Similarity NPD6585 Discontinued
0.7027 Intermediate Similarity NPD1610 Phase 2
0.7025 Intermediate Similarity NPD3540 Phase 1
0.7018 Intermediate Similarity NPD5710 Approved
0.7018 Intermediate Similarity NPD6808 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data